Cite
MLA Citation
Atsushi Hiraoka et al.. “Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.” Cancer medicine, vol. 12, 2023, pp. 325–334. http://access.bl.uk/ark:/81055/vdc_100173980230.0x00000a